Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases

被引:5
|
作者
Benitez Ramos, Dunia Barbara [1 ]
Cabrera Ortega, Michel [2 ]
Castro Hevia, Jesus [3 ]
Dorantes Sanchez, Margarita [3 ]
Aleman Fernandez, Ailema Amelia [3 ]
Castaneda Chirino, Osmin [3 ]
Cruz Cardentey, Marlenis [3 ]
Martinez Lopez, Frank [3 ]
Falcon Rodriguez, Roylan [3 ]
机构
[1] Cardioctr Pediat William Soler, Dept Pediat Cardiol, San Francisco E-100 & Perla, Havana, Cuba
[2] Cardioctr Pediat William Soler, Sect Arrhythmia & Cardiac Pacing, 100 & Perla, Havana, Cuba
[3] Inst Cardiol & Cirugia Cardiovasc, Serv Arrhythmia & Cardiac Pacing, 17 & Paseo,Plaza Revoluc, Havana, Cuba
关键词
Electrocardiographic markers; Implantable cardioverter-defibrillator; Appropriate shocks; Congenital heart disease; FRAGMENTED QRS COMPLEX; SUDDEN CARDIAC DEATH; TORSADE-DE-POINTES; HIGH-RISK PATIENTS; LONG-QT SYNDROME; QUALITY-OF-LIFE; HYPERTROPHIC CARDIOMYOPATHY; T-WAVE; VENTRICULAR-TACHYCARDIA; REPAIRED TETRALOGY;
D O I
10.1007/s00246-017-1711-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implantable cardioverter-defibrillators (ICDs) are increasingly utilized in patients with congenital heart disease (CHD). Prediction of the occurrence of shocks is important if improved patient selection is desired. The electrocardiogram (ECG) has been the first-line tool predicting the risk of sudden death, but data in CHD patients are lacking. We aim to evaluate the predictive value of electrocardiographic markers of appropriate therapy of ICD in young people with CHD. We conducted a prospective, longitudinal study, in twenty-six CHD patients (mean age 24.7 +/- 5.3 years) who underwent first ICD implantation. Forty-two age- and diagnosis-matched controls were recruited. Twelve-lead ECG and 24 h Holter analysis were performed during a mean follow-up of 38.9 months. Data included heart rate, heart rate variability, QRS duration (QRSd), QTc interval and its dispersion, Tpeak-Tend (Tp-Te) interval and its dispersion, presence of fragmented QRS (fQRS), T wave alternans, atrial arrhythmias, and non-sustained ventricular tachycardia. Implant indication was primary prevention in ten cases (38.5%) and secondary prevention in 16 (61.5%). Overall, 17 subjects (65.3%) received at least one appropriate and effective ICD discharge. fQRS was present in 64.7% of cases with ICD therapy compared with patients without events or controls (p < 0.0001). Tp-e and Tp-e dispersion were significantly prolonged in patients with recurrences (113.5 and 37.2 ms) versus patients without ICD discharge (89.6 and 24.1 ms) or controls (72.4 and 19.3 ms) (p < 0.0001 and p < 0.0001, respectively). On univariate Cox regression analysis QRSd (hazard ratio: 1.19 per ms, p = 0.003), QTc dispersion (hazard ratio: 1.57 per ms, p = 0.002), fQRS (hazard ratio: 3.58 p < 0.0001), Tp-e (hazard ratio: 2.27 per ms, p < 0.0001), and Tp-e dispersion (hazard ratio: 4.15 per ms, p < 0.0001), emerged as strong predictors of outcome. On multivariate Cox analysis fQRS, Tp-e and Tp-e dispersion remained in the model. The presence of fQRS, and both Tp-e and Tp-e dispersion are useful ECG tools in daily clinical practice to identify CHD patients at risk for appropriate ICD therapy.
引用
收藏
页码:1663 / 1671
页数:9
相关论文
共 50 条
  • [1] Electrocardiographic Markers of Appropriate Implantable Cardioverter-Defibrillator Therapy in Young People with Congenital Heart Diseases
    Dunia Bárbara Benítez Ramos
    Michel Cabrera Ortega
    Jesús Castro Hevia
    Margarita Dorantes Sánchez
    Ailema Amelia Alemán Fernández
    Osmin Castañeda Chirino
    Marlenis Cruz Cardentey
    Frank Martínez López
    Roylan Falcón Rodríguez
    Pediatric Cardiology, 2017, 38 : 1663 - 1671
  • [2] Implantable cardioverter-defibrillator therapy in congenital heart disease
    McLeod, Christopher J.
    Kapa, Suraj
    Asirvatham, Samuel J.
    EXPERT REVIEW OF MEDICAL DEVICES, 2010, 7 (01) : 1 - 3
  • [3] ECHOCARDIOGRAPHIC MARKERS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY
    Shi, Yang
    Cho, Chi
    Garlie, Lydia
    Perez, Ruth
    Shearer, Robyn
    Sulemanjee, Nasir
    Zwicke, Dianne
    Hastings, Thomas
    Cheema, Omar
    Thohan, Vinay
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A913 - A913
  • [4] Incidence of Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Heart Failure Treated With Combined Cardiac Resynchronization Plus Implantable Cardioverter-Defibrillator Therapy Versus Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Ahn, Chul
    Tsai, Fausan S.
    Lai, Hoang M.
    Gandhi, Kaushang
    Amin, Harshad
    Frishman, William H.
    Kalapatapu, Kumar
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (01) : 37 - 40
  • [5] Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication
    Schaer, Beat
    Kuehne, Michael
    Reichlin, Tobias
    Osswald, Stefan
    Sticherling, Christian
    EUROPACE, 2016, 18 (02): : 227 - 231
  • [6] Statins Reduce Appropriate Cardioverter-Defibrillator Shocks and Mortality in Patients With Failure and Combined Heart Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy
    Desai, Harit
    Aronow, Wilbert S.
    Tsai, Fausan S.
    Ahn, Chu
    Lai, Hoang M.
    Amin, Harshad
    Gandhi, Kaushang
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 14 (03) : 176 - 179
  • [7] Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease
    Wang, Linda
    Javadekar, Neeraj
    Rajagopalan, Ananya
    Rogovoy, Nichole M.
    Haq, Kazi T.
    Broberg, Craig S.
    Tereshchenko, Larisa G.
    HEART RHYTHM, 2020, 17 (05) : 860 - 869
  • [8] Subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease
    Njoo, R.
    Lennerz, C.
    Friedrich, L.
    Bock, M.
    Fetcu, A.
    Schaarschmidt, C.
    Kolb, C.
    Tutarel, O.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
    Nault, Michael A.
    McIntyre, William F.
    Simpson, Christopher S.
    Redfearn, Damian P.
    Abdollah, Hoshiar
    Brennan, F. James
    Baranchuk, Adrian
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2010, 15 (02) : 181 - 183
  • [10] Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease
    Tomaske, Maren
    Bauersfeld, Urs
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 : S35 - S37